Source Register
Sources ARKA uses — what each costs to use, and who paid for it to exist.
Last updated: August 14, 2026
Overview
Vol III §25.1 item 12 — one page for the external sources that inform a shipped number or clinical surface, with type, licence status, conflict-of-interest class, GRADE certainty where it applies, evidence domain (imaging vs analogous-domain), version, and date. This is where the ACR-labels question, the ACR/Optum error, and the guidelines question are answered at once: if it is not here, it does not influence a shipped ARKA figure.
Related: How ARKA validates · /risk · /baseline · Evaluation criteria.
72 classified sources. Canonical machine artefact: lib/sources/data.json.
Single-specialty vs primary evidence
Where a single-specialty source and primary evidence both assign a 1–9 rating to the same cell, they diverge in 0 of 0 paired cells. Single-specialty sources rate imaging higher than primary evidence in 0 of those cells, and lower in 0. Mean absolute gap among diverging cells is 0 points. This is a finding about the field, not a claim that one source type is correct.
| Slice | Paired cells (n) | Diverge | Higher than primary | Lower than primary | Mean |Δ| |
|---|---|---|---|---|---|
| Single-specialty vs primary | 0 | 0 | 0 | 0 | 0 |
Where a single-specialty source and primary evidence both assign a 1–9 rating to the same cell, a gap of two or more points is a named divergence. The primary rating governs; the down-weight that resolved the disagreement is shown. Cells without a paired per-source rating cannot enter the table. This is a finding about the field, not a claim that one source type is correct. Method.
Register
By licence status
- public domain30
- open licence4
- licensed to ARKA0
- cited only, not redistributed35
- not licensed — referenced by citation3
By COI class
- none34
- society with a financial interest in the service7
- vendor-authored3
- payer-authored0
- government28
By GRADE certainty
- high0
- moderate6
- low14
- very low2
- not rated (N/A)50
By evidence domain
- imaging8
- analogous-domain12
- methodological1
We rate certainty only where certainty is a meaningful concept. A dataset is not evidence for a claim; it is the raw material for one.
Showing 72 of 72 classified sources.
guideline (1)
| Source | Domain | Licence | COI | GRADE | Version | Date | Used by |
|---|---|---|---|---|---|---|---|
USPSTF D-rated services USPSTF Legacy licence text: `federal-public` GRADE — moderate: USPSTF D ratings require at least moderate certainty of no net benefit or net harm for the rated service; ARKA cites the D-rated service catalogue for deferred expansion, not a pooled nudge effect. | — | public domain | government | GRADE moderateUSPSTF D ratings require at least moderate certainty of no net benefit or net harm for the rated service; ARKA cites the D-rated service catalogue for deferred expansion, not a pooled nudge effect. | USPSTF current as of retrieval | 2026-08-07 | ARKA-TCOC lvs-cervical-over-65 lvs-psa-over-75 |
measure specification (5)
| Source | Domain | Licence | COI | GRADE | Version | Date | Used by |
|---|---|---|---|---|---|---|---|
Change Healthcare / Rivet Health (secondary summary) Vendor industry denials index; cited for avoidable-denial rates, not used as a clinical measure codeset. Not applicable — this is a measure specification or codeset, not an effect estimate. | — | cited only, not redistributed | vendor-authored | — | as cited in lib/roi/roi-model.ts | 2026-08-11 | ROI |
Milliman MedInsight Health Waste Calculator (with VBID Health) Milliman / VBID Health Legacy licence text: `licensed-do-not-embed` — do not embed, reverse-engineer or “model” Not applicable — this is a measure specification or codeset, not an effect estimate. | — | not licensed — referenced by citation | vendor-authored | — | Named comparator only; no version embedded | 2026-08-07 | ARKA-TCOC |
NCQA HEDIS — e.g. Use of Imaging Studies for Low Back Pain (LBP) NCQA Professional society that licenses the named code set or measure product; ARKA cites identifiers only and does not redistribute the corpus. Legacy licence text: `licensed-do-not-embed` — reference by name only; do not ship value sets Not applicable — this is a measure specification or codeset, not an effect estimate. | — | not licensed — referenced by citation | society with a financial interest in the service | — | HEDIS MY as published by NCQA (not embedded) | 2026-08-07 | ARKA-TCOC |
CMS / HHS Professional society that licenses the named code set or measure product; ARKA cites identifiers only and does not redistribute the corpus. Legacy licence text: `public-academic` Primary anchor for measure definitions: lvi-asympt-cardiac, lvi-carotid-asympt, lvi-headache-imaging, lvi-lbp-imaging, lvi-msk-early-mri, lvi-preop-cxr, lvi-preop-echo, lvi-preop-stress, lvi-repeat-ctap, lvi-sinusitis-imaging, lvi-syncope-imaging. Not applicable — this is a measure specification or codeset, not an effect estimate. | — | cited only, not redistributed | society with a financial interest in the service | — | 2014 print; methods supplement | 2026-08-07 | ARKA-TCOC lvi-asympt-cardiac lvi-carotid-asympt lvi-headache-imaging lvi-lbp-imaging lvi-msk-early-mri lvi-preop-cxr lvi-preop-echo lvi-preop-stress lvi-repeat-ctap lvi-sinusitis-imaging lvi-syncope-imaging |
The Dartmouth Institute for Health Policy & Clinical Practice (Elwyn / Barr) Registered for use with the CollaboRATE authors (registration form). Three-item patient-reported shared-decision measure; ARKA adopts the published top-score (top-box) rule without modifying item wording, response scale, or scoring. Not applicable — this is a measure specification or instrument, not an effect estimate. | — | open licence | none | — | CollaboRATE adult 0–9 top-score scoring (published) | 2013-01-01 | ARKA-SDM lib/sdm/measurement.ts lib/appropriateness/dimensions.ts |
peer-reviewed trial (21)
| Source | Domain | Licence | COI | GRADE | Version | Date | Used by |
|---|---|---|---|---|---|---|---|
Bhayana et al., *Radiology* 2025 (314:2) — "Leveraging LLMs to Generate Clinical Histories for Oncologic Imaging Requisitions" Radiology (RSNA) Independent peer-reviewed academic publication (or Cochrane review); not society-, vendor-, or payer-authored. Legacy licence text: cited only GRADE — very low: observational LLM evaluation (clinical-history generation for oncologic imaging requisitions); non-randomised, single-study, technology-specific — prior art for IRE, not an ARKA intervention effect. | imaging | cited only, not redistributed | none | GRADE very lowobservational LLM evaluation (clinical-history generation for oncologic imaging requisitions); non-randomised, single-study, technology-specific — prior art for IRE, not an ARKA intervention effect. | as published | 2026-08-08 | ARKA-IRE |
Annals of Internal Medicine Independent peer-reviewed academic publication (or Cochrane review); not society-, vendor-, or payer-authored. Legacy licence text: Published academic Practice-feedback design guidance (15 suggestions); cited for peer-comparison packet design. GRADE — low: non-randomised design-guidance synthesis (15 suggestions); starts low as expert/methods consensus drawn from A&F experience, not a trial of those suggestions as an intervention package. | analogous-domain | cited only, not redistributed | none | GRADE lownon-randomised design-guidance synthesis (15 suggestions); starts low as expert/methods consensus drawn from A&F experience, not a trial of those suggestions as an intervention package. | 2016;164(6) | 2026-08-07 | /evidence/nudges /risk ARKA-TCOC |
Journal of the American College of Radiology Harvey L. Neiman Health Policy Institute / Radiology Associates authors. Optum Clinformatics matched case-control. 7-day post-visit imaging 2.4 pp lower after telemedicine (29.7% relative reduction). JACR is an American College of Radiology journal — COI class society with financial interest in the service. Volume/utilization outcome, not appropriateness rating. GRADE — low: peer-reviewed publication typed as a trial/evidence source; defaulted to low pending indication-specific grading (not rated high). | imaging | cited only, not redistributed | society with a financial interest in the service | GRADE lowpeer-reviewed publication typed as a trial/evidence source; defaulted to low pending indication-specific grading (not rated high). | 2025 Jul;22(7):1047-1055; 23,431,032 matched office visits (2021) | 2025-07-17 | /evidence/methodology docs/governance/VIRTUAL_ENCOUNTER_POSITION.md |
Journal of the American College of Radiology Independent published source cited on /evidence/nudges and /risk; not redistributed. Independent academic authors (Duke University / Duke Primary Care / Duke Radiology). PubMed record has no abstract and no GrantList. No vendor funding disclosed in the bibliographic record. COI class assigned from author affiliations and the PubMed record — full text not read. Same Duke Primary Care cohort. One result reported on two denominators — volume (halpern-2021) and cost (clark-randall-2021). Not two independent findings. Overlap is inferred from shared network, overlapping authors (Halpern, Clark-Randall, Woodall, Shah), and the cost paper citing the volume paper; the JACR full text was not read. GRADE — low: observational pre-post design, no concurrent control group, no reported risk adjustment, single health system, effect not separable from secular trend. Effect size is not a reason to upgrade — the size of an effect and the certainty of an effect are different quantities. | imaging | cited only, not redistributed | none | GRADE lowobservational pre-post design, no concurrent control group, no reported risk adjustment, single health system, effect not separable from secular trend. Effect size is not a reason to upgrade — the size of an effect and the certainty of an effect are different quantities. | 2021 Jul;18(7):947–950; cost denominator of the Duke Primary Care dashboard | 2021-07-01 | /evidence/nudges /risk ARKA-TCOC |
Eur Radiol 2025 — "Applying large language model for automated quality scoring of radiology requisitions using standardized criteria" Radiology (RSNA) Independent peer-reviewed academic publication (or Cochrane review); not society-, vendor-, or payer-authored. Legacy licence text: cited only GRADE — very low: observational LLM evaluation (automated requisition quality scoring); non-randomised, single-study — prior art for IRE, not an ARKA intervention effect. | imaging | cited only, not redistributed | none | GRADE very lowobservational LLM evaluation (automated requisition quality scoring); non-randomised, single-study — prior art for IRE, not an ARKA intervention effect. | as published | 2026-08-08 | ARKA-IRE |
Journal of General Internal Medicine Independent published source cited on /evidence/nudges and /risk; not redistributed. Independent academic authors (Duke University / Duke Primary Care). No vendor funding disclosed in the abstract or in the available full-text extract (PMC7859117). PubMed record has no GrantList. COI class assigned from the abstract plus the available full-text extract; a dedicated funding statement was not located in the extract. Same Duke Primary Care cohort. One result reported on two denominators — volume (halpern-2021) and cost (clark-randall-2021). Not two independent findings. Overlap is inferred from shared network, overlapping authors (Halpern, Clark-Randall, Woodall, Shah), and the cost paper citing the volume paper; the JACR full text was not read. GRADE — low: observational pre-post design, no concurrent control group, no reported risk adjustment, single health system, effect not separable from secular trend. Effect size is not a reason to upgrade — the size of an effect and the certainty of an effect are different quantities. | imaging | cited only, not redistributed | none | GRADE lowobservational pre-post design, no concurrent control group, no reported risk adjustment, single health system, effect not separable from secular trend. Effect size is not a reason to upgrade — the size of an effect and the certainty of an effect are different quantities. | 2021; 159 providers / 1,358,644 outpatient encounters / 3 years | 2021-01-01 | /evidence/nudges /risk ARKA-TCOC |
Cochrane Collaboration Independent peer-reviewed academic publication (or Cochrane review); not society-, vendor-, or payer-authored. Legacy licence text: Published / Cochrane Cochrane systematic review of audit-and-feedback effects on professional practice. GRADE — moderate: Cochrane systematic review of randomised audit-and-feedback trials; starts high, downgraded one level for inconsistency/heterogeneity across interventions and settings (and residual indirectness to imaging utilisation). | analogous-domain | cited only, not redistributed | none | GRADE moderateCochrane systematic review of randomised audit-and-feedback trials; starts high, downgraded one level for inconsistency/heterogeneity across interventions and settings (and residual indirectness to imaging utilisation). | Most recently updated 2025 per build book | 2026-08-07 | /evidence/nudges /risk ARKA-TCOC |
Johns Hopkins University Academic price comparison study; independent of society/vendor/payer authorship of ARKA measures. GRADE — low: observational price-comparison study (commercial vs Medicare radiology); starts low as non-randomised evidence; used for ROI unit prices, not as an intervention effect. | imaging | cited only, not redistributed | none | GRADE lowobservational price-comparison study (commercial vs Medicare radiology); starts low as non-randomised evidence; used for ROI unit prices, not as an intervention effect. | as cited in lib/roi/roi-model.ts | 2026-08-11 | ROI |
Science Defaults / organ-donation framing study; cited for default-effect transfer, not imaging-specific effect. GRADE — low: observational / framing evidence on defaults (organ donation); starts low as non-randomised, high indirectness to imaging order defaults. | analogous-domain | cited only, not redistributed | none | GRADE lowobservational / framing evidence on defaults (organ donation); starts low as non-randomised, high indirectness to imaging order defaults. | as cited in lib/tcoc/content/nudge-evidence.ts | 2026-08-12 | ARKA-TCOC /evidence/nudges /risk |
JAMA Network Open Medicare FFS cohort (2019–2022). High practice-level telehealth use was associated with lower rates of some office-based low-value services and no association with higher imaging-based low-value measures. Independent academic authors (University of Michigan). COI class from abstract and affiliations — full conflict statement not independently verified. GRADE — low: peer-reviewed publication typed as a trial/evidence source; defaulted to low pending indication-specific grading (not rated high). | analogous-domain | cited only, not redistributed | none | GRADE lowpeer-reviewed publication typed as a trial/evidence source; defaulted to low pending indication-specific grading (not rated high). | 2024 Nov 7;7(11):e2445436; 577,928 beneficiaries / 2,552 Michigan primary care practices | 2024-11-07 | /evidence/methodology docs/governance/VIRTUAL_ENCOUNTER_POSITION.md |
JAMA Network Independent peer-reviewed academic publication (or Cochrane review); not society-, vendor-, or payer-authored. Legacy licence text: Published academic Independent published source cited on /evidence/nudges and /risk; not redistributed. GRADE — low: prespecified secondary analysis of the Meeker 2016 cluster-RCT (Linder et al. 2017), 12-month post-removal follow-up only; downgraded for indirectness (antibiotics → imaging) and imprecision (single follow-up window, decaying effects). | analogous-domain | cited only, not redistributed | none | GRADE lowprespecified secondary analysis of the Meeker 2016 cluster-RCT (Linder et al. 2017), 12-month post-removal follow-up only; downgraded for indirectness (antibiotics → imaging) and imprecision (single follow-up window, decaying effects). | 2017 (12 months post-removal) | 2026-08-07 | /evidence/nudges /risk ARKA-TCOC |
JAMA Network Independent peer-reviewed academic publication (or Cochrane review); not society-, vendor-, or payer-authored. Legacy licence text: Published academic Independent cluster-RCT (Meeker et al. 2016); also listed from the TCOC register. Independent published source cited on /evidence/nudges and /risk; not redistributed. GRADE — moderate: randomised, low risk of bias; downgraded one level for indirectness — the population and the clinical decision are antibiotics, not imaging. | analogous-domain | cited only, not redistributed | none | GRADE moderaterandomised, low risk of bias; downgraded one level for indirectness — the population and the clinical decision are antibiotics, not imaging. | 2016; 47 practices / 248 clinicians / 18 months | 2026-08-07 | /evidence/nudges /risk ARKA-TCOC ROI |
Meeker D et al. JAMA 2016 (accountable justification arm) American Medical Association Professional society that licenses the named code set or measure product; ARKA cites identifiers only and does not redistribute the corpus. Legacy licence text: Published academic GRADE — moderate: cluster-randomised, low risk of bias; downgraded one level for indirectness — accountable justification was tested on antibiotic prescribing, not imaging orders. | analogous-domain | cited only, not redistributed | society with a financial interest in the service | GRADE moderatecluster-randomised, low risk of bias; downgraded one level for indirectness — accountable justification was tested on antibiotic prescribing, not imaging orders. | 2016 | 2026-08-09 | ARKA-AJ |
JAMA Internal Medicine Cluster-RCT of nudging guideline-concordant antibiotic prescribing (Meeker et al. 2014); precursor to the 2016 three-arm trial. GRADE — moderate: cluster-randomised antibiotic-prescribing nudge trial; downgraded one level for indirectness to imaging utilisation. | analogous-domain | cited only, not redistributed | none | GRADE moderatecluster-randomised antibiotic-prescribing nudge trial; downgraded one level for indirectness to imaging utilisation. | as cited in lib/tcoc/content/nudge-evidence.ts | 2026-08-12 | ARKA-TCOC /evidence/nudges /risk |
JAMA Internal Medicine Health-system EHR default redesign study (generic prescribing); cited for default-effect mechanism. GRADE — low: health-system EHR default redesign study (before/after); non-randomised, different clinical decision (generics), cited for mechanism transfer only. | analogous-domain | cited only, not redistributed | none | GRADE lowhealth-system EHR default redesign study (before/after); non-randomised, different clinical decision (generics), cited for mechanism transfer only. | as cited in lib/tcoc/content/nudge-evidence.ts | 2026-08-12 | ARKA-TCOC /evidence/nudges /risk |
JAMA Cardiology Cluster-RCT of behavioural interventions on statin prescribing; cited for transfer of accountable-justification / peer-comparison mechanisms. GRADE — moderate: cluster-randomised, low risk of bias; downgraded one level for indirectness — statin prescribing, not imaging orders. | analogous-domain | cited only, not redistributed | none | GRADE moderatecluster-randomised, low risk of bias; downgraded one level for indirectness — statin prescribing, not imaging orders. | as cited in lib/tcoc/content/nudge-evidence.ts | 2026-08-12 | ARKA-TCOC /evidence/nudges /risk |
Clinical Imaging Independent academic authors (NewYork-Presbyterian / Weill Cornell Medicine and collaborators). No vendor funding disclosed in the abstract. PubMed record has no GrantList. COI class assigned from the abstract — full text not read. GRADE — low: observational pre-post quality-improvement design, no concurrent control group, no reported risk adjustment, two academic centres in one metro, effect not separable from secular trend. Effect size is not a reason to upgrade — the size of an effect and the certainty of an effect are different quantities. | imaging | cited only, not redistributed | none | GRADE lowobservational pre-post quality-improvement design, no concurrent control group, no reported risk adjustment, two academic centres in one metro, effect not separable from secular trend. Effect size is not a reason to upgrade — the size of an effect and the certainty of an effect are different quantities. | 2022 Feb;82:156–160; PMID 34844100 | 2022-02-01 | /evidence/nudges /risk ARKA-IP |
Journal of Risk and Uncertainty Foundational status-quo-bias paper; cited for behavioural mechanism framing on public nudge pages. GRADE — low: foundational behavioural-economics paper on status-quo bias; not an imaging intervention trial — certainty is for the mechanism claim only. | analogous-domain | cited only, not redistributed | none | GRADE lowfoundational behavioural-economics paper on status-quo bias; not an imaging intervention trial — certainty is for the mechanism claim only. | as cited in lib/tcoc/content/nudge-evidence.ts | 2026-08-12 | ARKA-TCOC /evidence/nudges /risk |
Marketing Science Thaler mental-accounting paper ("peanut effect"); cited for incentive-design framing on public nudge pages. GRADE — low: foundational mental-accounting paper; cited for incentive-design framing, not a graded clinical effect estimate. | analogous-domain | cited only, not redistributed | none | GRADE lowfoundational mental-accounting paper; cited for incentive-design framing, not a graded clinical effect estimate. | as cited in lib/tcoc/content/nudge-evidence.ts | 2026-08-12 | ARKA-TCOC /evidence/nudges /risk |
Updating a Claims-Based Measure of Low-Value Services Applicable to Medicare Fee-for-Service Beneficiaries. *J Gen Intern Med.* 2022. CMS / HHS Independent peer-reviewed academic publication (or Cochrane review); not society-, vendor-, or payer-authored. Legacy licence text: `public-academic` ICD-10 carry-forward for the eleven LVI measure definitions. GRADE — low: observational methods paper on ICD-9→ICD-10 carry-forward for claims measures; not a randomised intervention effect — certainty is for coding continuity, downgraded for observational design and imprecision of GEM mapping. | imaging | cited only, not redistributed | none | GRADE lowobservational methods paper on ICD-9→ICD-10 carry-forward for claims measures; not a randomised intervention effect — certainty is for coding continuity, downgraded for observational design and imprecision of GEM mapping. | 2022 JGIM | 2026-08-07 | ARKA-TCOC lvi-asympt-cardiac lvi-carotid-asympt lvi-headache-imaging lvi-lbp-imaging lvi-msk-early-mri lvi-preop-cxr lvi-preop-echo lvi-preop-stress lvi-repeat-ctap lvi-sinusitis-imaging lvi-syncope-imaging |
Wagner / Fretheim / Penfold / Cochrane EPOC ITS guidance Cochrane Collaboration Independent peer-reviewed academic publication (or Cochrane review); not society-, vendor-, or payer-authored. Legacy licence text: Published academic / Cochrane EPOC GRADE — low: methodological standards for interrupted time series (Cochrane EPOC), not an intervention effect estimate; rated low as established methods guidance rather than a graded clinical effect. | methodological | cited only, not redistributed | none | GRADE lowmethodological standards for interrupted time series (Cochrane EPOC), not an intervention effect estimate; rated low as established methods guidance rather than a graded clinical effect. | As cited in Part A.8 (Wagner 12/12 default) | 2026-08-07 | ARKA-TCOC |
government dataset (12)
| Source | Domain | Licence | COI | GRADE | Version | Date | Used by |
|---|---|---|---|---|---|---|---|
AHRQ CCSR (Clinical Classifications Software Refined) AHRQ Legacy licence text: `federal-public` Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | `v2026.1` (DXCCSR) | 2026-08-07 | ARKA-TCOC |
AHRQ Elixhauser Comorbidity Software Refined AHRQ Legacy licence text: `federal-public` Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | Refined ICD-10-CM `v2026.1` | 2026-08-07 | ARKA-TCOC |
CMS DE-SynPUF (Data Entrepreneurs’ Synthetic PUF) CMS / HHS Legacy licence text: `federal-public` (synthetic) Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | 2008–2010 5% / 20 datasets | 2026-08-07 | ARKA-TCOC |
CMS ordering/referring NPI enforcement (advanced imaging; PECOS; Item 17b / K3) CMS / HHS Legacy licence text: `federal-public` Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | Policy effective 2014-01-06; dictionaries as retrieved | 2026-08-07 | ARKA-TCOC |
CMS-HCC V28 (payment year 2024+; full phase-in 2026) CMS / HHS Legacy licence text: `federal-public` Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | V28 | 2026-08-07 | ARKA-TCOC |
KFF Nonprofit policy research organisation analysis of Marketplace denial data; no financial interest in ARKA outputs. Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | none | — | as cited in lib/roi/roi-model.ts | 2026-08-11 | ROI |
Medicare Physician & Other Practitioners — by Geography & Service CMS / HHS Legacy licence text: `federal-public` Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | CMS release year under ingest | 2026-08-07 | ARKA-TCOC |
Medicare Physician & Other Practitioners — by Provider and Service (`data.cms.gov`) CMS / HHS Legacy licence text: `federal-public` Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | CMS release year under ingest | 2026-08-07 | ARKA-TCOC |
CMS / HHS Legacy licence text: `federal-public` Primary anchor for measure definitions: lvi-asympt-cardiac, lvi-carotid-asympt, lvi-headache-imaging, lvi-lbp-imaging, lvi-msk-early-mri, lvi-preop-cxr, lvi-preop-echo, lvi-preop-stress, lvi-repeat-ctap, lvi-sinusitis-imaging, lvi-syncope-imaging. Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | Report year matched to measure-year under test | 2026-08-07 | ARKA-TCOC lvi-asympt-cardiac lvi-carotid-asympt lvi-headache-imaging lvi-lbp-imaging lvi-msk-early-mri lvi-preop-cxr lvi-preop-echo lvi-preop-stress lvi-repeat-ctap lvi-sinusitis-imaging lvi-syncope-imaging |
MSSP / ACO Shared Savings Program PUFs U.S. federal government Legacy licence text: `federal-public` Not applicable — this is a government claims dataset, not an effect estimate. | — | public domain | government | — | Performance year under calibration | 2026-08-07 | ARKA-TCOC |
Synthea (MITRE) + CMS RIF exporter CMS / HHS Open-source tooling used in ARKA's pipeline; authors have no financial interest in ARKA's clinical or utilization outputs. Legacy licence text: Open-source (Synthea licence as published) Not applicable — this is a government claims dataset, not an effect estimate. | — | open licence | none | — | Seed `SYNTHEA_GOLDEN_SEED` (`lib/tcoc/ingest/adapters/synthea.ts`); jar pinned at gen time | 2026-08-07 | ARKA-TCOC |
National Conference of State Legislatures Watchlist trigger state-ed-utilisation-legislation. Search 2026-08-23 (enacted only) for emergency department / ED / advanced imaging / CT / MRI / utilization review / utilisation review / prior authorization / utilization management. No enacted state statute requires utilisation review of advanced imaging in the emergency department. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | cited only, not redistributed | none | — | Enacted-only Power BI database, retrieved 2026-08-23 | 2026-08-23 | policy-watchlist /compliance/regulatory-standing |
regulatory document (19)
| Source | Domain | Licence | COI | GRADE | Version | Date | Used by |
|---|---|---|---|---|---|---|---|
HHS Office of Inspector General Independent published source cited for ROI model figures; not redistributed. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | as cited in lib/roi/roi-model.ts | 2026-08-11 | ROI |
HL7 FHIR R4 ServiceRequest HL7 International HL7 is a standards development organisation; FHIR ServiceRequest is an open standard with no financial interest in imaging utilization. Legacy licence text: Open HL7 FHIR Not applicable — this is a regulatory or policy document, not an effect estimate. | — | open licence | none | — | R4 | 2026-08-09 | ARKA-AJ |
CMS Innovation Center States LEAD is a 10-year voluntary model, 1 January 2027 through 31 December 2036; launches following the conclusion of ACO REACH at the end of 2026. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | Page last modified 2026-07-20 | 2026-07-20 | ARKA-TCOC /lead /risk |
CMS Innovation Center For ACOs entering in PY 2027, Base Years are CY 2024, CY 2025, and CY 2026; historical baseline stays fixed over the ACO’s participation (no rebasing within the ten-year horizon). Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | July 2026 | 2026-07-01 | ARKA-TCOC /lead /risk /pricing expand-ii |
CMS Innovation Center LEAD model design. Ten-year voluntary ACO model beginning 1 January 2027; ten-year performance period without rebasing. The no-rebasing term is the load-bearing fact in the Expand II compounding / remaining-term willingness-to-pay model. Retrieved 19 August 2026. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | as published on cms.gov | 2026-03-01 | ARKA-TCOC /lead /pricing expand-ii |
CMS Innovation Center Source for the two risk options (Global 100% / Professional 50%), the 3% quality withhold, the 1.75-3% Global explicit discount, the 10/30/60 base-year weighting, and the regional efficiency / prior savings adjustments. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | as published | 2026-08-12 | lead-benchmark lead-brief /lead risk roi |
CMS Innovation Center ACO REACH concludes at the end of 2026; LEAD is the Innovation Center successor. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | as published on cms.gov | 2026-07-20 | ARKA-TCOC /lead /risk |
CMS Innovation Center Model live 1 January 2026 in NJ, OH, OK, TX, AZ, WA; PA requests from 5 January 2026 for services on/after 15 January 2026. CMS: non-payment recommendations determined by appropriately licensed clinicians. Verified 2026-08-11 vs Provider & Supplier Operational Guide 4.0 — 13 active service categories; advanced imaging (diagnostic CT/MR/PET/NM) is not among them; Deep Brain Stimulation (NCD 160.24) and Percutaneous Image-Guided Lumbar Decompression (NCD 150.13) delayed. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | Page last modified 2026-08-04 | 2026-01-01 | ARKA-INS never-auto-deny /governance/never-do /compliance/regulatory-standing |
California Legislature Effective 1 January 2025. Requires that a denial, delay, or modification of health care services based on medical necessity be made by a licensed physician or other health care provider competent to evaluate the clinical issues — not by an algorithm alone. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | Chapter 879, Statutes of 2024 | 2025-01-01 | ARKA-INS never-auto-deny /governance/never-do |
CMS Watchlist trigger cy2027-site-neutral-imaging. Proposed rule; site-neutral payment for imaging without contrast in excepted off-campus PBDs is not finalized. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | CMS-1850-P, issued 2 July 2026 | 2026-07-02 | policy-watchlist /compliance/regulatory-standing |
CMS Innovation Center Watchlist trigger lead-application-milestones. No application dates for a LEAD cohort after PY2027 are published in this FAQ. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | July 2026 FAQ | 2026-07-01 | policy-watchlist /compliance/regulatory-standing |
U.S. Congress Watchlist trigger root-act-enacted stageHistory: introduced 2025-05-08 (Blackburn / Cortez Masto). Not enacted. Would revive a Medicare advanced-imaging AUC consultation mandate without the original claims-reporting mechanism. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | 119th Congress, S.1692 | 2025-05-08 | policy-watchlist /compliance/regulatory-standing |
U.S. Congress Watchlist trigger root-act-enacted stageHistory: introduced 2025-10-10 (Harshbarger / Moore). House vehicle later used for Patients First Act packaging of ROOT provisions. Not enactment. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | 119th Congress, H.R.5737 | 2025-10-10 | policy-watchlist /compliance/regulatory-standing |
U.S. Congress Watchlist trigger root-act-enacted stageHistory: included_in_package 2026-07-15. A bill in a package is not a rule and is not demand. Enactment has not occurred. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | 119th Congress, H.R.5737 — ROOT inclusion 2026-07-15 | 2026-07-15 | policy-watchlist /compliance/regulatory-standing |
CMS Attribution and historical benchmarks for Shared Savings Program and LEAD ACOs are set by CMS programme rule (assignment methodology and LEAD payment/benchmark specifications), not by ARKA. ARKA consumes customer-supplied or CMS-rule assignments as read-only inputs. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | MSSP Shared Savings and Losses, Assignment, and Quality Performance Standard Methodology Specifications Version 14 | 2026-08-07 | ARKA-TCOC /compliance/regulatory-standing no-attribution-or-risk-adjustment |
Texas Legislature / Texas Department of Insurance Texas HB 3459 (87th Legislature, 2021) as amended by HB 3812 (89th Legislature, 2025). 90% approval-rate threshold (statute) over a 12-month evaluation period; fully insured TDI-regulated plans only — self-funded ERISA plans are out of scope. Companion TDI FAQ retrieved the same day: https://www.tdi.texas.gov/health/hb3459-faq.html. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | HB 3812 enrolled, effective 2025-09-01 | 2025-09-01 | gold-card lib/goldcard/statutes.ts /ins/provider/gold-card |
Centers for Medicare & Medicaid Services Living NCD index. Version + retrieval date is the pin; a later MCD edit is not this source. The ncd adapter returns indeterminate unless sourced clinical criteria are on the order — it does not guess medical necessity. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | Medicare Coverage Database retrieval 2026-08-18 (IOM Pub 100-03) | 2026-08-18 | lib/coverage/adapters/ncd.ts lib/coverage/data/ncd-index.ts lib/coverage/registry.ts |
Centers for Medicare & Medicaid Services LCDs differ by MAC. The mac-lcd adapter refuses to evaluate an order whose jurisdiction it does not know rather than falling back to a default LCD. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | Medicare Coverage Database retrieval 2026-08-18 | 2026-08-18 | lib/coverage/adapters/mac-lcd.ts lib/coverage/data/mac-jurisdictions.ts lib/coverage/registry.ts |
Office of the National Coordinator for Health Information Technology Voluntary ARKA publication of predictive DSI source attributes. ARKA is not a certified Health IT Module. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | public domain | government | — | HTI-1 final rule predictive DSI source attributes | 2024-01-09 | framework-crosswalk lib/standard/crosswalk.ts lib/governance/dsi-attributes.ts /trust /docs/model-card |
professional society statement (8)
| Source | Domain | Licence | COI | GRADE | Version | Date | Used by |
|---|---|---|---|---|---|---|---|
American Medical Association AMA physician survey on prior authorization burden; AMA also licenses CPT. Not applicable — this is a professional society statement or survey, not an effect estimate. | — | cited only, not redistributed | society with a financial interest in the service | — | as cited in lib/roi/roi-model.ts | 2026-08-11 | ROI |
AMA CPT® code set (identifiers only) American Medical Association Professional society that licenses the named code set or measure product; ARKA cites identifiers only and does not redistribute the corpus. Legacy licence text: Licensed identifiers cited only — do not embed CPT long descriptors or the codebook as a corpus; representative study codes used as FHIR Coding.code values Not applicable — this is a professional society statement or survey, not an effect estimate. | — | cited only, not redistributed | society with a financial interest in the service | — | CPT as cited in `MODALITY_TO_CPT` | 2026-08-09 | ARKA-AJ |
CAQH Multi-stakeholder industry index for administrative transaction costs; cited for PA cost/time figures only. Not applicable — this is a professional society statement or survey, not an effect estimate. | — | cited only, not redistributed | none | — | as cited in lib/roi/roi-model.ts | 2026-08-11 | ROI |
Choosing Wisely (ABIM Foundation) ABIM Foundation ABIM Foundation Choosing Wisely campaign — recommendations cited; mark not used in ARKA UI. No financial interest in imaging utilization outcomes. Legacy licence text: Recommendations public; mark held by ABIM Foundation — cite, do not brand Not applicable — this is a professional society statement or survey, not an effect estimate. | — | cited only, not redistributed | none | — | Recommendation texts as cited per measure | 2026-08-07 | ARKA-TCOC lvs-homocysteine-screening lvs-t3-hypothyroid lvs-vitamin-d-screening |
MGMA Professional society practice survey / cost figures; cited for administrative rework cost only. Not applicable — this is a professional society statement or survey, not an effect estimate. | — | cited only, not redistributed | society with a financial interest in the service | — | as cited in lib/roi/roi-model.ts | 2026-08-11 | ROI |
New England Journal of Medicine NEJM perspective on nudge units in health care delivery; cited for institutional framing, not as a graded intervention effect. Not applicable — this is a professional society statement or survey, not an effect estimate. | — | cited only, not redistributed | none | — | as cited in lib/tcoc/content/nudge-evidence.ts | 2026-08-12 | ARKA-TCOC /evidence/nudges /risk |
Yale University Press Popular book synthesizing behavioural-economics literature (defaults / status quo); cited for framing on public nudge pages, not as an ARKA effect estimate. Not applicable — this is a professional society statement or survey, not an effect estimate. | — | cited only, not redistributed | none | — | as cited in lib/tcoc/content/nudge-evidence.ts | 2026-08-12 | ARKA-TCOC /evidence/nudges /risk |
The Joint Commission / Coalition for Health AI RUAIH element titles used as crosswalk field names. ARKA is not Joint Commission certified for Responsible Use of AI. Not applicable — this is a regulatory or policy document, not an effect estimate. | — | cited only, not redistributed | none | — | Initial guidance 17 September 2025; voluntary certification announced May 2026 | 2025-09-17 | framework-crosswalk lib/standard/crosswalk.ts lib/governance/ai-package.ts /trust /governance/ai |
technical specification (5)
| Source | Domain | Licence | COI | GRADE | Version | Date | Used by |
|---|---|---|---|---|---|---|---|
HL7 International / Financial Management Work Group (Da Vinci Project) Pinned by docs/DAVINCI_CONFORMANCE_DECISION_2026-09.md. Package hl7.fhir.us.davinci-crd 2.2.1 (package.manifest.json date 20260327113228). Permanent STU home: https://hl7.org/fhir/us/davinci-crd/2.2.1/. Not applicable — this is a technical specification, not an effect estimate. | — | cited only, not redistributed | none | — | 2.2.1 | 2026-03-27 | docs/DAVINCI_CONFORMANCE_DECISION_2026-09.md lib/coverage/types.ts lib/coverage/adapters/davinci-dtr.ts lib/davinci/crd.ts |
HL7 International / Financial Management Work Group (Da Vinci Project) Pinned by docs/DAVINCI_CONFORMANCE_DECISION_2026-09.md. Package hl7.fhir.us.davinci-dtr 2.2.0 (package.manifest.json date 20260327160408). Permanent STU home: https://hl7.org/fhir/us/davinci-dtr/2.2.0/. Not applicable — this is a technical specification, not an effect estimate. | — | cited only, not redistributed | none | — | 2.2.0 | 2026-03-27 | docs/DAVINCI_CONFORMANCE_DECISION_2026-09.md lib/coverage/types.ts lib/coverage/adapters/davinci-dtr.ts lib/davinci/dtr.ts |
HL7 International / Financial Management Work Group (Da Vinci Project) Pinned by docs/DAVINCI_CONFORMANCE_DECISION_2026-09.md. Package hl7.fhir.us.davinci-pas 2.2.1 (package.manifest.json date 20260327135848). Permanent STU home: https://hl7.org/fhir/us/davinci-pas/2.2.1/. Not applicable — this is a technical specification, not an effect estimate. | — | cited only, not redistributed | none | — | 2.2.1 | 2026-03-27 | docs/DAVINCI_CONFORMANCE_DECISION_2026-09.md lib/coverage/types.ts lib/coverage/adapters/davinci-dtr.ts lib/davinci/pas.ts |
ARKA-INS coverage adapter (clinical engine wrap) ARKA Wraps determineCoverage() in lib/ins/coverage-adapter.ts as one CriteriaSource among five. Records a caller-supplied determination; it does not look up a clinical rulebook. Not applicable — this is a technical specification, not an effect estimate. | — | not licensed — referenced by citation | vendor-authored | — | ins-coverage-adapter-1 | 2026-08-18 | lib/ins/coverage-adapter.ts lib/coverage/adapters/arka-clinical.ts lib/coverage/registry.ts |
Coalition for Health AI (CHAI) Open-source Applied Model Card schema. Vendored XSD at docs/chai/applied-model-card-v0.2.xsd. Field names used verbatim; not a claim of CHAI endorsement. Not applicable — this is a technical specification or instrument, not an effect estimate. | — | open licence | none | — | v0.2 | 2024-11-22 | framework-crosswalk lib/standard/crosswalk.ts lib/standard/chai-model-card.ts /trust /api/standard/model-card |
evidence panel record (1)
| Source | Domain | Licence | COI | GRADE | Version | Date | Used by |
|---|---|---|---|---|---|---|---|
ARKA Standing Evidence Panel Sealed panel record (6 decision(s); charter 1.0.0). Cite JSON or PDF at the stable API URL. Not applicable — an evidence panel record attests to a certainty adjudication; it is not primary clinical evidence for the underlying claim (Prompt 33.7). | — | public domain | none | — | sha256:bbcd860ddbdf00f202db9fcf8df4e4b915caaa8cc3bb1eed716efefb7970275f | 2026-08-23 | lib/governance/evidence-panel/record.ts app/governance/evidence-panel/page.tsx lib/aiie/knowledge-matrix |
Pending classification
No sources are currently held out of the register. When a new external source cannot be mapped to licence and COI without guessing, it appears here instead of being invented.